{"generic":"Urea","drugs":["Aqua Care","Aquaphilic w\/Carbamide","Carmol","Epimide 50","Gordon's Urea","Keralac","Keratol 40","Urea","Vanamide"],"mono":{"0":{"id":"643730-s-0","title":"Generic Names","mono":"Urea"},"1":{"id":"643730-s-1","title":"Dosing and Indications","sub":{"0":{"id":"643730-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Atopic dermatitis:<\/b> apply topically to affected area(s) twice daily<\/li><li><b>Cerebral edema:<\/b> 500 to 1500 mg\/kg IV as 30% solution in D5W, D10W or invert sugar at rate not exceeding 4 mL\/min; MAX 120 g\/day urea<\/li><li><b>Congenital ichthyosis of skin:<\/b> apply topically to affected area(s) twice daily<\/li><li><b>Debridement:<\/b> apply topically to affected area(s) twice daily<\/li><li><b>Dry skin:<\/b> apply topically to affected area(s) twice daily<\/li><li><b>Eczema:<\/b> apply topically to affected area(s) twice daily<\/li><li><b>Elective termination of pregnancy:<\/b> after transabdominal tap of the amniotic sac, administer 40% to 60% urea solution (in D5W), equal to the volume of amniotic fluid removed, via intra-amniotic infusion; MAX volume 200 to 250 mL (usually 80 g urea) administered slowly while observing for adverse reactions<\/li><li><b>Glaucoma:<\/b> 500 to 1500 mg\/kg IV as 30% solution in D5W, D10W or invert sugar at rate not exceeding 4 mL\/min; MAX 120 g\/day urea<\/li><li><b>Hyperkeratosis:<\/b> apply topically to affected area(s) twice daily<\/li><li><b>Psoriasis:<\/b> apply topically to affected area(s) twice daily<\/li><\/ul>"},"1":{"id":"643730-s-1-5","title":"Pediatric Dosing","mono":"<ul><li><b>Cerebral edema:<\/b> 500 to 1500 mg\/kg IV as 30% solution in D5W, D10W or invert sugar at rate not exceeding 4 mL\/min<\/li><li><b>Cerebral edema:<\/b> (under 2 yr of age) 100 mg\/kg IV as 30% solution in D5W, D10W or invert sugar at rate not exceeding 4 mL\/min<\/li><\/ul>"},"3":{"id":"643730-s-1-7","title":"Indications","mono":"<b>Non-FDA Labeled Indications<\/b><ul><li>Atopic dermatitis<\/li><li>Cerebral edema<\/li><li>Congenital ichthyosis of skin<\/li><li>Debridement<\/li><li>Dry skin<\/li><li>Eczema<\/li><li>Elective termination of pregnancy<\/li><li>Glaucoma<\/li><li>Hyperkeratosis<\/li><li>Psoriasis<\/li><\/ul>"}}},"3":{"id":"643730-s-3","title":"Contraindications\/Warnings","sub":[{"id":"643730-s-3-9","title":"Contraindications","mono":"<ul><li>severe renal impairment<\/li><li>hypersensitivity to urea or other product ingredients<\/li><li>active intracranial hemorrhage<\/li><li>dehydration<\/li><li>liver failure<\/li><li>hereditary fructose intolerance (aldolase deficiency) (invert sugar diluent)<\/li><li>ruptured membranes (aborption)<\/li><li>cervical stenois, uterine fibroids (abortion)<\/li><\/ul>"},{"id":"643730-s-3-10","title":"Precautions","mono":"<ul><li>liver function impairment (increased ammonia load)<\/li><li>kidney function impairment<\/li><li>diabetes, sickle cell disease (increased hemolysis\/thrombosis risk)<\/li><\/ul>"},{"id":"643730-s-3-11","title":"Pregnancy Category","mono":"Fetal risk has been demonstrated. (TH)<br\/>"},{"id":"643730-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"4":{"id":"643730-s-4","title":"Drug Interactions","sub":{"1":{"id":"643730-s-4-14","title":"Major","mono":"<ul><li>Arsenic Trioxide (theoretical)<\/li><li>Droperidol (theoretical)<\/li><li>Levomethadyl (theoretical)<\/li><\/ul>"},"2":{"id":"643730-s-4-15","title":"Moderate","mono":"<ul>Licorice (probable)<\/ul>"}}},"5":{"id":"643730-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Cardiovascular:<\/b>Syncope<\/li><li><b>Gastrointestinal:<\/b>Nausea, Vomiting<\/li><li><b>Neurologic:<\/b>Headache<\/li><li><b>Psychiatric:<\/b>Disorientated<\/li><li><b>Renal:<\/b>Oliguria<\/li><\/ul>"},"6":{"id":"643730-s-6","title":"Drug Name Info","sub":{"0":{"id":"643730-s-6-17","title":"US Trade Names","mono":"<ul><li>Carmol<\/li><li>Aquaphilic w\/Carbamide<\/li><li>Aqua Care<\/li><li>Keralac<\/li><li>Vanamide<\/li><li>Epimide 50<\/li><li>Keratol 40<\/li><li>Gordon's Urea<\/li><\/ul>"},"2":{"id":"643730-s-6-19","title":"Class","mono":"<ul><li>Diuretic, Osmotic<\/li><li>Emollient<\/li><li>Keratolytic<\/li><li>Nutriceutical<\/li><li>Uterine Stimulant<\/li><\/ul>"},"3":{"id":"643730-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"643730-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"643730-s-7","title":"Mechanism Of Action","mono":"<ul><li>Parenteral-Local: The mechanism by which urea causes fetal death and abortion has not been elucidated but may be related to damage of decidual cells by hypertonic urea and subsequent release of prostaglandins, which induce uterine contractions . Hypertonic urea induces fetal death .<\/li><li>Systemic: Cerebral edema-Elevates blood plasma osmolality, resulting in enhanced flow of water from tissues, including the brain and cerebrospinal fluid, into interstitial fluid and plasma. As a result, cerebral edema, elevated intracranial pressure, and cerebrospinal fluid volume and pressure may be reduced. This effect is evident early in the course of infusion as long as a gradient between plasma and intracellular urea exists. As urea diffuses into the cells and the gradient diminishes, the effect diminishes. <\/li><li>Glaucoma-Elevates blood plasma osmolality, resulting in enhanced flow of water from the eye into plasma and a consequent reduction in intraocular pressure.<\/li><li>As the concentration of urea in glomerular filtrate increases, reabsorption of a proportional amount of water is prevented, resulting in increases in rate and volume of urine flow.<\/li><\/ul>"},"8":{"id":"643730-s-8","title":"Pharmacokinetics","sub":{"2":{"id":"643730-s-8-25","title":"Metabolism","mono":"Systemic: GI tract: Metabolites: ammonia and carbon dioxide <br\/>"},"3":{"id":"643730-s-8-26","title":"Excretion","mono":"Parenteral-Local: Renal <br\/>"},"4":{"id":"643730-s-8-27","title":"Elimination Half Life","mono":"Systemic: 1.17 h<br\/>"}}},"9":{"id":"643730-s-9","title":"Administration","mono":"<ul><li><b>Intravenous<\/b><br\/><ul><li>dilute to a 30% solution with D5W or D10W<\/li><li>infusion rate should not exceed 4 mL\/min<\/li><li>do not administer through the same administration set with blood<\/li><li>in elderly patients, do not infuse through veins in the lower extremities<\/li><\/ul><\/li><li><b>Topical<\/b><br\/><ul><li>when applying to skin, rub in until completely absorbed<\/li><li>when applying to nails, let dry uncovered or apply and cover with bandage<\/li><li>avoid contact with eyes, lips or mucous membranes<\/li><\/ul><\/li><\/ul>"},"10":{"id":"643730-s-10","title":"Monitoring","mono":"<ul><li>cerebral edema: intracranial pressure<\/li><li>dermatologic conditions: symptomatic improvement<\/li><li>glaucoma: intraocular pressure<\/li><li>blood ammonia levels in patients with liver impairment<\/li><\/ul>"},"11":{"id":"643730-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/><ul><li>Topical Cream: 10 %, 20 %, 39 %, 40 %, 45 %<\/li><li>Topical Gel\/Jelly: 40 %<\/li><li>Topical Lotion: 10 %, 40 %, 45 %<\/li><li>Topical Suspension: 40 %<\/li><\/ul><\/li><li><b>Aluvea<\/b><br\/>Topical Cream: 39 %<br\/><\/li><li><b>Aqua Care<\/b><br\/><ul><li>Topical Cream: 10 %<\/li><li>Topical Lotion: 10 %<\/li><\/ul><\/li><li><b>Aquaphilic w\/Carbamide<\/b><br\/>Topical Ointment: 10 %, 20 %<br\/><\/li><li><b>BP-50% Urea Emulsion<\/b><br\/>Topical Emulsion: 50 %<br\/><\/li><li><b>Carb-O-Philic\/20<\/b><br\/>Topical Cream: 20 %<br\/><\/li><li><b>Carb-O-Phillic 40<\/b><br\/><ul><li>Topical Cream: 40 %<\/li><li>Topical Gel\/Jelly: 40 %<\/li><\/ul><\/li><li><b>CEM-Urea<\/b><br\/>Topical Gel\/Jelly: 45 %<br\/><\/li><li><b>Gordon's Urea<\/b><br\/>Topical Cream: 22 %, 40 %<br\/><\/li><li><b>Gormel Creme<\/b><br\/>Topical Cream: 20 %<br\/><\/li><li><b>Gormel Ten<\/b><br\/>Topical Lotion: 10 %<br\/><\/li><li><b>Gormel<\/b><br\/>Topical Cream: 20 %<br\/><\/li><li><b>Hydro 35<\/b><br\/>Topical Foam: 35 %<br\/><\/li><li><b>Hydro 40<\/b><br\/>Topical Foam: 40 %<br\/><\/li><li><b>Kerafoam 42<\/b><br\/>Topical Foam: 42 %<br\/><\/li><li><b>Kerafoam<\/b><br\/>Topical Foam: 30 %<br\/><\/li><li><b>Keralac<\/b><br\/><ul><li>Topical Cream: 50 %<\/li><li>Topical Gel\/Jelly: 50 %<\/li><\/ul><\/li><li><b>Lanaphilic w\/Urea<\/b><br\/>Topical Ointment: 10 %, 20 %<br\/><\/li><li><b>Latrix<\/b><br\/>Topical Suspension: 50 %<br\/><\/li><li><b>Nutraplus<\/b><br\/><ul><li>Topical Cream: 10 %<\/li><li>Topical Lotion: 10 %<\/li><\/ul><\/li><li><b>Quinnostik<\/b><br\/>Topical Solution: 50 %<br\/><\/li><li><b>Rea Lo 39<\/b><br\/>Topical Cream: 39 %<br\/><\/li><li><b>Rea Lo 40<\/b><br\/><ul><li>Topical Cream: 40 %<\/li><li>Topical Lotion: 40 %<\/li><\/ul><\/li><li><b>Remeven<\/b><br\/>Topical Cream: 50 %<br\/><\/li><li><b>RevitaDerm 40<\/b><br\/>Topical Cream: 40 %<br\/><\/li><li><b>U-Kera<\/b><br\/>Topical Cream: 40 %<br\/><\/li><li><b>Ultra Mide 25<\/b><br\/>Topical Lotion: 25 %<br\/><\/li><li><b>Umecta<\/b><br\/><ul><li>Topical Emulsion: 40 %<\/li><li>Topical Foam: 40 %<\/li><li>Topical Suspension: 40 %<\/li><\/ul><\/li><li><b>Uramaxin<\/b><br\/><ul><li>Topical Cream: 45 %<\/li><li>Topical Foam: 20 %<\/li><li>Topical Gel\/Jelly: 45 %<\/li><\/ul><\/li><li><b>Ureacin-10<\/b><br\/>Topical Lotion: 10 %<br\/><\/li><li><b>Ureacin-20<\/b><br\/>Topical Cream: 20 %<br\/><\/li><li><b>Urea Nail Gel<\/b><br\/>Topical Gel\/Jelly: 45 %<br\/><\/li><li><b>X-Viate<\/b><br\/><ul><li>Topical Cream: 40 %<\/li><li>Topical Gel\/Jelly: 40 %<\/li><li>Topical Lotion: 40 %<\/li><\/ul><\/li><\/ul>"},"13":{"id":"643730-s-13","title":"Clinical Teaching","mono":"<ul><li>The intravenous form may cause syncope, nausea, vomiting, headache, disorientation, or oliguria.<\/li><li>It is important to maintain adequate hydration during intravenous therapy to prevent dehydration.<\/li><li>When applying topical preparations to nails, advise patient to let drug dry uncovered or apply and cover with bandage.<\/li><li>Patient should not apply cosmetics, or other skin products to treated skin areas when using topical preparations. Advise patient to avoid drug contact with eyes, lips, or mucous membranes.<\/li><\/ul>"}}}